PMI has thrown its support behind a new law in Russia that has been approved by the government and submitted to parliament. The law aims to regulate the production and sale of tobacco products, tobacco derivatives, nicotine-containing products, and their raw materials through national oversight.
Pharmo International has expressed support for a new initiative in Russia aimed at strengthening regulations and implementing comprehensive and systematic monitoring of the tobacco and nicotine product market. The company stated that the bill will enhance existing measures against illegal trade and introduce new measures to reduce the likelihood of illegal products entering the Russian market. These new measures include monitoring production equipment and requiring licenses for raw material production and importation.
The company also noted that the implementation of the new law will help increase government budget revenue.
According to 2FIRSTS, the final version of the bill will include provisions stating that producing, purchasing, storing, supplying (including importing into or exporting from the Russian Federation) tobacco products, tobacco goods, nicotine-containing products, and their production materials on a large scale without the appropriate license will be subject to fines of 500,000 to 1 million rubles (45,000 to 90,000 yuan) or the equivalent of 1 to 3 years of the offender's income, or imprisonment for 1 to 3 years.
Further Reading:
The Russian Ministry of Finance has suggested imposing criminal penalties for the sale of counterfeit cigarettes, among other offenses. The maximum penalty could be up to three years of forced labor or a fine.
Reference:
Philip Morris seeks to strengthen control over tobacco sales.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
